Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01989598. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Melphalan and Amifostine Followed By One or Two Autologous or Syngeneic Stem Cell Transplants and Maintenance Therapy in Treating Patients With Stage II-III Multiple Myeloma
ClinicalTrials.gov study NCT00217438. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03201250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
ClinicalTrials.gov study NCT00784823. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02099539. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01034553. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01919086. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LCAR-B38M Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
ClinicalTrials.gov study NCT03090659. IPD Sharing: UNDECIDED. Countries: 0. Publications: 4.
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06356571. IPD Sharing: YES. Countries: 1. Publications: 0.
A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06799026. IPD Sharing: YES. Countries: 1. Publications: 0.
Effect of Combination of Bortezomib/Dexamethasone/Zoledronic Acid on Bone Disease in Patients With Multiple Myeloma Relapsed After 1-3 Prior Lines of Therapy
ClinicalTrials.gov study NCT00972959. IPD Sharing: Not stated. Countries: 1. Publications: 0.
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT03837509. IPD Sharing: NO. Countries: 3. Publications: 0.
Sunitinib in Treating Patients With Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT00514137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stem Cell Transplant With or Without Tbo-filgrastim in Treating Patients With Multiple Myeloma or Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT03317899. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
ClinicalTrials.gov study NCT01534143. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Evaluate the Combination of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
ClinicalTrials.gov study NCT01056276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00612716. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission
ClinicalTrials.gov study NCT04221178. IPD Sharing: YES. Countries: 1. Publications: 0.
PTK/ZK as Post Transplant Maintenance Therapy in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00240162. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01374217. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.